Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Biogen Inc. (BIIB) had Revenue of $2.53B for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$2.53B
Net Income	$466.50M
Cost of Goods Sold	$674.40M
Gross Profit	$1.86B
Operating Expenses	$1.94B
Operating Income	$591.40M
Non-Operating Income/Expense	$-34.10M
Pre-Tax Income	$557.30M
Normalized Pre-Tax Income	$557.30M
Income after Taxes	$466.50M
Income from Continuous Operations	$466.50M
Consolidated Net Income/Loss	$466.50M
Normalized Income after Taxes	$466.50M
EBIT	$591.40M
EBITDA	$855.10M
Weighted-Average Shares Outstanding (Basic)	146.60M
Weighted-Average Shares Outstanding (Diluted)	147.10M
Earnings per Share (EPS) (Basic)	$3.18
Earnings per Share (EPS) (Diluted)	$3.17
Balance Sheet Financials
Current Assets	$8.94B
Property, Plant, and Equipment	$3.08B
Long-Term Assets	$20.27B
Total Assets	$29.21B
Current Liabilities	$3.29B
Long-Term Debt	$6.29B
Long-Term Liabilities	$7.71B
Total Liabilities	$11.00B
Common Equity	$18.21B
Tangible Shareholders Equity	$2.38B
Shareholders Equity	$18.21B
Common Shares Outstanding	146.70M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.69B
Cash Flow from Investing Activities	$-139.40M
Cash Flow from Financial Activities	$-164.90M
Beginning Cash	$2.38B
End Cash	$3.86B
Increase/Decrease in Cash	$1.49B
Stock-Based Compensation	$231.20M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.72
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.26
Debt to Equity Ratio	0.35
Gross Margin	73.39%
Operating Margin	23.33%
EBIT Margin	23.33%
EBITDA Margin	--
Pre-Tax Profit Margin	21.99%
Profit Margin	18.40%
Free Cash Flow	$1.58B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.31
Receiveable Turnover	1.84
Days Sales in Receivables	48.79
Return on Equity	2.56%
Return on Tangible Equity	19.56%
Return on Assets	1.60%
Return on Investments	1.90%
Book Value Per Share	$124.11
Free Cash Flow per Share	$10.76
Operating Cash Flow per Share	$11.51

Data from Zacks Investment Research, Inc.